Your browser doesn't support javascript.
loading
Human papillomavirus (HPV) vaccination in a privately funded program in Ghana: A qualitative case study.
Marfo, Emmanuel; Salami, Bukola; Adjei, Charles; MacDonald, Shannon.
Afiliación
  • Marfo E; Faculty of Nursing, University of Alberta, Edmonton, AB, Canada.
  • Salami B; Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Adjei C; School of Nursing and Midwifery, University of Ghana, Legon, Accra, Ghana.
  • MacDonald S; Faculty of Nursing, University of Alberta, Edmonton, AB, Canada.
Hum Vaccin Immunother ; 20(1): 2397219, 2024 Dec 31.
Article en En | MEDLINE | ID: mdl-39255822
ABSTRACT
HPV vaccination is one of the safest and most effective interventions against HPV-related cancers. From 2013 to 2018, HPV vaccination was piloted in Ghana in preparation for a national program. Yet, at the time of this study, there was no publicly funded HPV vaccination program in Ghana. We explored an existing privately funded HPV vaccination program in Ghana to identify challenges and gaps and to gather insights to inform vaccination practice and national policy. This study used a qualitative case study research design. We conducted semi-structured interviews on experiences, barriers, and challenges in HPV vaccination at the Greater-Accra Regional Hospital between October 1 and November 26, 2023. Participants (N = 16) included HPV vaccinators (n = 8) and program/policy leaders (n = 8). Our thematic analysis focused on HPV vaccination processes, practice challenges, and policy interests. Four main themes emerged from our analyses. Our findings revealed many challenges faced by the HPV vaccination program. These include a lack of guiding policy/framework for the HPV vaccination program, an emphasis on sexual history, cervical screening, and HPV DNA test in determining vaccination eligibility by vaccinators, and a lack of formal provider and recipient HPV education programs. Although many vaccinators advocated for a universal HPV program, some policy/program leaders were reluctant to prioritize HPV vaccination advocacy due to their focus on acute health concerns. A vaccination program without a policy can be limited in quality and efficiency, as there will be no accountability and sustainability measures. We recommend the need to develop standardized guidelines to support evidence-based HPV vaccination practice.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunación / Programas de Inmunización / Infecciones por Papillomavirus / Investigación Cualitativa / Vacunas contra Papillomavirus Límite: Adult / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Hum Vaccin Immunother Año: 2024 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunación / Programas de Inmunización / Infecciones por Papillomavirus / Investigación Cualitativa / Vacunas contra Papillomavirus Límite: Adult / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: Hum Vaccin Immunother Año: 2024 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Estados Unidos